US 12,496,275 B2Granted

Drug delivery methods and compositions

AssigneeMayo Foundation for Medical Education and Research

InventorsDebabrata Mukhopadhyay, Vijay S. Madamsetty, Krishnendu Pal

Life of this patent

Estimating the term…

Abstract

The present application provides liposomal compositions containing anti-cancer agents and tumor-targeting lipopeptides. The present application also provides nanodiamond complexes and particles as carriers for anti-cancer agents.

Claims22

Dependent claims

A polypeptide, or a pharmaceutically acceptable salt thereof, comprising SEQ ID NO:

Dependencies are inferred from the claim text.

Facts

Application: 17/618,389Filed 16 Jun 2020 · us provisional application
Priority: 17 Jun 2019
Published: US 2022/0257515 A118 Aug 2022
Granted: 16 Dec 2025
Term ends: Not estimatedThe source records don’t support an estimate.

Classification37 codes

A61K 9/1275
Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant: lipoproteins or protein-free…
A61K 31/165
Amides, e.g. hydroxamic acids: having aromatic rings, e.g. colchicine, atenolol, progabide
A61K 31/337
Having oxygen as the only ring hetero atom, e.g. fungichromin: having four-membered rings, e.g. taxol
A61K 31/343
Having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide: condensed with a carbocyclic ring, e.g. coumaran,…

Family

Application62/862,525Us provisional application · filed 17 Jun 2019
US 2022/0257515 A1Pre-grant publication · published 18 Aug 2022
US 12,496,275 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results